Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr-Jun;41(2):67-74.
doi: 10.4103/joc.joc_108_23. Epub 2024 Apr 24.

Application of CytoPath®Easy Vials in Cervical Cancer Screening: Self-Sampling Approach

Affiliations

Application of CytoPath®Easy Vials in Cervical Cancer Screening: Self-Sampling Approach

Sílvia P M Fernandes et al. J Cytol. 2024 Apr-Jun.

Abstract

Context: CytoPath®Easy kit (DiaPath S.p.A.) offers a major advantage compared to other commercially available kits available for the screening of cervical cancer, as it does not require additional equipment for sample processing. Using this methodology, collected epithelial cells are immersed in a preservative liquid before setting as a thin layer on a slide via gravity sedimentation.

Aims: To evaluate the suitability of the CytoPath®Easy kit for the processing of cervical samples, detection of pre-neoplastic lesions, and nucleic preservation and extraction for HR-HPV diagnosis.

Materials and methods: A total of 242 self-sampled cervical specimens were utilized, with 192 collected in CytoPath®Easy vials and 50 collected and processed using the ThinPrepTM for comparative analysis. The samples underwent processing, Papanicolaou staining, and microscopic evaluation for morphological parameters. The extracted nucleic acids were assessed for purity and integrity, and the detection of high-risk human papillomavirus (HR-HPV) was carried out using the Alinitym HR HPV system kit (Abbott Laboratórios Lda).

Results: Both methods demonstrated effective performance, enabling the morphological assessment of the cervical epithelium. Statistical analysis indicated that ThinPrepTM yielded significantly better results in terms of cellularity. Conversely, CytoPath®Easy exhibited superior performance in terms of the quantity of extracted DNA and its degree of purification. Concerning the time consumed during processing, both methods were comparable, with the CytoPath®Easy methodology standing out for its cost-effectiveness, as it does not necessitate additional instruments and consumables.

Conclusions: The novel CytoPath®Easy methodology proves effective in preserving both nucleic acids and cell morphology characteristics, two crucial features for cervical cancer screening.

Keywords: Cervical cytology; HR-HPV; nucleic acids; pre-neoplastic lesions.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Microscopic evaluation of cell features analyzed after sample processing using each methodology, Papanicolaou staining, and mounting. Global characteristics of the cell imprint are observed in (a) (ThinPrepTM) and (d) (CytoPath®Easy) at a low magnification field (100x); background, cellularity, and cell morphology preservation characteristics, as well as nuclear detail, hematoxylin color and cytoplasmic differentiation are observed at high magnification–400x (b, c (ThinPrepTM), e and f (CytoPath®Easy))
Figure 2
Figure 2
Graphic representation of global characteristics scores-cellularity, imprint thickness/cell overlap, presence of undesirable background, and preservation of cell morphology. Results showed both CytoPath®Easy and ThinPrepTM provide similar results, although significant statistical differences were observed in cellularity
Figure 3
Figure 3
Graphic representation of staining properties. Similar mean values were found with regard to nuclear detail, hematoxylin color, nuclear differentiation, cytoplasmic staining, and differentiation
Figure 4
Figure 4
Graphic representation of results obtained by a spectrophotometric reading of DNA extracted from ThinPrepTM and CytoPath®Easy samples. A260/280, A260/A230, and DNA yield were quantified and compared. Significant differences were observed on A260/A230 (P < 0.0001). NanoDrop 1000 spectrophotometer reader reveals a bigger concentration of extracted DNA from CytoPath®Easy vials
Figure 5
Figure 5
Representative image of electrophoresis gel (1.5% agarose) running samples of both methodologies- ThinPrepTM and CytoPath®Easy, captured on a UV light reader

References

    1. Human papillomavirus and Related Disease Report - HPV center. Available from: https://hpvcentre.net/statistics/reports/XWX.pdf. [Last accessed on 2023 Mar 29]
    1. Eun TJ, Perkins RB. Screening for cervical cancer. Med Clin North Am. 2020;104:1063. - PMC - PubMed
    1. Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical cancer screening: Past, present, and future. Sex Med Rev. 2020;8:28–37. - PubMed
    1. Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynecol Obst. 2021;155:28–44. - PMC - PubMed
    1. Maver PJ, Poljak M. Primary HPV-based cervical cancer screening in Europe: Implementation status, challenges, and future plans. Clin Microbiol Infect. 2020;26:579–83. - PubMed